CareDx: 3Q Earnings Snapshot

Associated Press |

BRISBANE, Calif. (AP) _ CareDx Inc. (CDNA) on Thursday reported a loss of $20 million in its third quarter.

The Brisbane, California-based company said it had a loss of 54 cents per share. Losses, adjusted for non-recurring costs and stock option expense, were 1 cent per share.

The molecular diagnostics company posted revenue of $21.2 million in the period, beating Street forecasts. Three analysts surveyed by Zacks expected $18.5 million.

CareDx expects full-year earnings in the range of $74 to $75 per share.

CareDx shares have more than tripled since the beginning of the year. In the final minutes of trading on Thursday, shares hit $27.74, climbing fivefold in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CDNA at https://www.zacks.com/ap/CDNA

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

CMX Gold & Silver Corp.

CMX Gold & Silver Corp is an exploration stage company. The Company is engaged in the acquisition, exploration and development of silver and copper/gold properties in the USA.